Application of targeted next-generation sequencing for pathogens diagnosis and drug resistance prediction in bronchoalveolar lavage fluid of pulmonary infections
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1590881 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Qiugui Xu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Laboratory, People's Hospital of Yangjiang, Yangjiang, Guangdong, China. Hauptthemen laut MEDLINE: Bronchoalveolar Lavage Fluid, High-Throughput Nucleotide Sequencing, Bacteria, Drug Resistance, Bacterial. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Recently, targeted next-generation sequencing (tNGS) have been extensively utilized for the identification of pathogens in pulmonary infections, there have been some studies systematically evaluating differences in the efficacy of tNGS and conventional microbiological tests (CMTs) in bronchoalveolar lavage fluid (BALF) specimens.
Methods
A retrospective analysis was conducted on 203 patients with pulmonary infections treated in one tertiary hospital from July 2023 to February 2024. BALF specimens underwent parallel testing via tNGS and CMTs. Pathogen detection consistency, the drug resistance genes concordance with phenotypic drug sensitivity, and clinical impact of tNGS-guided therapy adjustments were analyzed. Furthermore, two patients with complex infections were selected for tNGS microbiological surveillance to evaluate the efficacy of monitoring severe pneumonia.
Results
This study included 205 confirmed infectious BALF specimens (two patients were tested twice). tNGS identified 56 putative pathogens, compared to 20 by CMTs, with a significantly higher positive rate (99.5% vs. 35.6%, P <0.0001). The detection of pathogenic microorganisms using tNGS showed a high concordance rate with the results of CMTs. tNGS-guided therapy adjustments occurred in 17.2% (35/203) of patients. Resistance gene predictions aligned with the drug sensitivity results in 40% (6/15) of carbapenem-resistant organisms (CROs) and 80% (4/5) of methicillin-resistant Staphylococcus aureus (MRSA) cases. Additionally, for monitored two patients with severe pneumonia, the tNGS results were consistent with the culture and imaging test results during treatment.
Conclusions
The application of tNGS highlights its promise and significance in identifying potential pathogens, predicting drug resistance, and providing guidance for anti-infection therapies for severe pneumonia. It can be at least a complementary approach to CMTs reporting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Laboratory, People's Hospital of Yangjiang, Yangjiang, Guangdong, China.
- Department of Radiology, People's Hospital of Yangjiang, Yangjiang, Guangdong, China.
- Precision Medical Lab Center, People's Hospital of Yangjiang, Yangjiang, Guangdong, China.
- Clinical Laboratory, Chest Hospital of Zhengzhou University, Zhengzhou, Henan, China.
- Department of Respiratory and Critical Care Medicine, People's Hospital of Yangjiang, Yangjiang, Guangdong, China.
Zitieren
APA
Xu, Q., Chen, Q., Qiu, W., Liu, L., Zeng, W., Chen, J., Li, Y., Guo, Z., Rong, L., Chen, B., Yao, J., & Yang, L. (2025). Application of targeted next-generation sequencing for pathogens diagnosis and drug resistance prediction in bronchoalveolar lavage fluid of pulmonary infections. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1590881
Vancouver
Xu Q, Chen Q, Qiu W, Liu L, Zeng W, Chen J, et al. Application of targeted next-generation sequencing for pathogens diagnosis and drug resistance prediction in bronchoalveolar lavage fluid of pulmonary infections. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1590881
BibTeX
@article{Xu2025,
author = {Xu, Qiugui and Chen, Qiumei and Qiu, Wen and Liu, Lili and Zeng, Wan and Chen, Jinling and Li, Yangyang and Guo, Zhen and Rong, Ling and Chen, Bigui and Yao, Jinxiu and Yang, Liye},
title = {Application of targeted next-generation sequencing for pathogens diagnosis and drug resistance prediction in bronchoalveolar lavage fluid of pulmonary infections},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1590881}
}
EUVIMED